SGA
LXRX icon

Sector Gamma AS’s Lexicon Pharmaceuticals LXRX Stock Holding History

Sector Gamma AS’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-376,502
Closed -$2.09M – 35
2019
Q1 		$2.09M Sell
376,502
-486,100
-56% -$2.95M 0.34% 33
2018
Q4 		$5.73M Hold
862,602
– – 0.96% 27
2018
Q3 		$9.2M Hold
862,602
– – 1.44% 20
2018
Q2 		$10.4M Buy
862,602
+8,010
+0.9% +$81.9K 1.72% 18
2018
Q1 		$7.32M Buy
854,592
+17,400
+2% +$161K 1.32% 23
2017
Q4 		$8.27M Buy
837,192
+99,739
+14% +$1.04M 1.39% 25
2017
Q3 		$9.06M Buy
737,453
+114,798
+18% +$1.7M 1.38% 21
2017
Q2 		$10.2M Buy
622,655
+290,355
+87% +$4.5M 1.49% 21
2017
Q1 		$4.76M Buy
+332,300
New +$4.93M 0.76% 24

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return